Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Returned to the company President & C.E.O. returned 18,295 shares (to the company)
  2. 4 Returned to the company President, MGL returned 6,653 shares (to the company)
  3. 4 Returned to the company Chief Scientific Officer returned 5,544 shares (to the company)
  4. 4 Returned to the company E.V.P., General Counsel returned 5,544 shares (to the company)
  5. 4 Returned to the company Chief Financial Officer returned 6,653 shares (to the company)
  6. 4 Returned to the company President Assurex Health Inc. returned 2,897 shares (to the company)
  7. 4 Returned to the company Exec. VP International Ops returned 3,327 shares (to the company)
  8. 4 Returned to the company President Crescendo BioScience returned 4,958 shares (to the company)
  9. 4 Returned to the company President Myriad Oncology returned 1,664 shares (to the company)
  10. 4 Returned to the company President Myriad RBM, Inc. returned 2,952 shares (to the company)
  11. 4 Grant or award President Myriad RBM, Inc. acquired 27,000 shares (grant or award)
  12. 4 Grant or award President Crescendo BioScience acquired 35,000 shares (grant or award)
  13. 4 Grant or award Exec. VP International Ops acquired 27,000 shares (grant or award)
  14. 4 Grant or award President Assurex Health Inc. acquired 40,000 shares (grant or award)
  15. 4 Grant or award President, MGL acquired 60,000 shares (grant or award)
  16. 4 Grant or award Chief Scientific Officer acquired 50,000 shares (grant or award)
  17. 4 Grant or award E.V.P., General Counsel acquired 50,000 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 60,000 shares (grant or award)
  19. 4 Grant or award President & C.E.O. acquired 165,000 shares (grant or award)
  20. 4 Returned to the company Chief Scientific Officer returned 6,515 shares (to the company)

Page 26 of 65 · 1,294 filings